[at Bloomberg] – Celgene Corp. (CELG) was accused of promoting its cancer drug Thalomid and related compound Revlimid for uses not approved by U.S. regulators in a newly unsealed lawsuit filed by a former saleswoman. Thalomid, which the U.S. Food and Drug Administration has approved to treat multiple myeloma, is a new generation of thalidomide, a morning-sickness drug linked to birth defects in the 1960s and revived decades later to fight cancer, according to … [visit site to read more]
- The Boeing Company (NYSE:BA) – Boeing reports 17 new orders in weekly update
- Market Update on eBay Inc. (NASDAQ:EBAY) – Romanians accused of eBay scam
- Surface RT recovery image released to fix Windows RT 8.1 update issues – Microsoft Corporation (NYSE:MSFT)
